Latest Articles
![]() Migraine Associated With Increased Risk of Cardiovascular DiseaseAccording to research, women who have migraines with aura could be more likely to... |
![]() Insomnia and Short Sleep Duration Associated With Increased Mortality RiskAccording to research, men with insomnia and sleep duration of six or fewer hours... |
![]() Walnut Consumption Significantly Decreases LDL CholesterolResearchers have found that high-walnut-enriched diets significantly decreased total and LDL cholesterol for the... |
![]() Dietary Fat Linked to Pancreatic CancerAccording to a study, high intake of dietary fats from red meat and dairy... |
![]() New Evidence Why Repair of Myelin Fails in Multiple SclerosisResearch has uncovered new evidence suggesting that damage to nerve cells in people with... |
![]() Memory Test Helps Understand Parkinson's Disease Effect on BehaviorA new neuropsychological memory test developed by Dr. Mark Gluck, is helping to uncover... |
![]() Patient Receives Cardiac Stem Cells in Clinical TrialDoctors at the Cedars-Sinai Heart Institute have announced the completion of the first procedure... |
Most Read
![]() Home UVB Therapy for Psoriasis as Effective as Hospital TreatmentA study has concluded that for patients with psoriasis, treatment with ultraviolet B (UVB)... |
![]() Ginkgo Biloba Extract Offers Some Benefit for Multiple SclerosisMultiple sclerosis is a chronic neurological disease afflicting young and middle-aged adults, resulting in... |
![]() Green Tea Component Has Potential To Inhibit HIV InfectionA chemical that occurs naturally in green tea appears to prevent HIV-1 (the virus... |
![]() Drug Free Treatment for High Blood Pressure Successfully TestedResearchers have demonstrated the effectiveness of a drug free treatment for high blood pressure... |
![]() Fat in Urine Could Predict Whether Prostate Cancer is AggressiveAccording to research published in the British Journal of Cancer, tiny bubbles of fat... |
![]() Test Developed to Quickly Assess Alzheimer's Treatment EfficacyA test developed by scientists may help assess more quickly the ability of Alzheimer's... |
![]() Discovery Offers Hope for Diagnosis and Treatment of Alzheimer'sResearchers have made a discovery that offers new hope for the early diagnosis and... |
| ApoE4 Slows Brain's Ability to Eliminate Amyloid Beta in Alzheimer’s |
|
One of the primary characteristics of Alzheimer’s is the accumulation of amyloid-beta peptide (A-beta), something that is believed to be toxic to neurons and many other brain cells, and thus a contributor to the underlying cause of Alzheimer’s. Individuals carrying the ApoE4 gene have a greater risk of developing Alzheimer’s than individuals with other forms of the gene (APoE2 and APoE3). People who carry two copies of the ApoE4 gene have roughly eight to 10 times the risk of getting Alzheimer's than people who do not. Researchers at University of Rochester Medical Center have found that ApoE4 is the only known genetic risk factor for Alzheimer's that slows down the brain's ability to eliminate amyloid-beta. "Our latest findings help explain one of the major risk factors for Alzheimer's," said Zlokovic, lead researcher. "ApoE4 changes the brain's ability to rid itself of amyloid-beta. It's becoming more and more apparent that the brain's ability to clear out amyloid-beta, through the vascular system and across the blood-brain barrier, is central to the development of Alzheimer's." The brain uses a molecule called LRP1 to remove amyloid-beta from the brain speedily and efficiently into the body where it can be easily eliminated. The researchers found that there is another slower and less efficient molecule involved in the elimination of amyloid-beta known as very low-density lipoprotein receptor (VLDLR), which is especially active when amyloid is coupled to ApoE4 The researchers showed that speedy LRP1 is central to removing amyloid-beta when ApoE2 or ApoE3 is involved, with the slower VLDLR picking up some of the slack. But when the form of the gene that puts people at risk, ApoE4, is involved, VLDLR nearly alone is responsible for hauling the amyloid-beta away. Not only do the ApoE proteins help determine how quickly amyloid-beta is removed from the brain; the proteins actually couple with amyloid-beta in the brain to form sticky complexes. This gunk gathers around cells and is much more difficult to remove from the brain than free-floating amyloid-beta. 1. Berislav Zlokovic, et al. Alzheimer's gene slows brain's ability to export toxic protein. University of Rochester Medical Center. November 2008. Related Articles
|



















